The Alliance submitted comments on CMS’ recent proposals for Medicare Advantage plans in CY 2021 and 2022, expressing concern about the use of telehealth providers as a proxy for in-person care, opposing a second specialty tier in Part D, and urging improvements in the Quality Rating System. The Alliance also called for improvements in the definition of inappropriate prescribing of opioids and called for the agency to remove barriers to non-opioid pain treatment.

Alliance Letter to CMS on 2021 and 2022 MAPD Proposed Rule